Autoimmune Endocrine Disorders
An Introduction to Autoimmune Endocrine Disorders
The immune and endocrine system interact in complex ways, and multiple immune processes are involved in endocrine diseases. The most well-known autoimmune endocrine disease is type 1 diabetes (T1D), in which autoimmune responses result in the selective destruction of pancreatic β-cells. Other disorders resulting from autoimmune mediated tissue destruction include Grave’s disease, Hashimoto’s thyroiditis, and Addison’s disease Immune cells have been implicated in thyroid cancer development and progression, and have also been found in adipose tissue, where they appear to play a role in glucose metabolism in the context of obesity and type 2 diabetes (T2D).
Browse video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and peer-reviewed articles from the journal portfolio. This is complemented by a range of educational activities from our expert faculty, with patient outcomes at the forefront.
Autoimmune Endocrine Disorders Content
Stefano Del Prato, EASD 2020 – Highlights from the Virtual Meeting
We caught up with EASD President Stefano Del Prato (University of Pisa and University Hospital of Pisa) ahead of this year’s virtual meeting to hear about the key topics being discussed. Disclosures: Sterfano Del Prato has received research support from AstraZeneca, Boehringer Ingelheim, Merck Sharp & Dohme and served on the advisory board for Abbott, […]
Mikael Rydén, EASD 2020 – Research into Human White Adipocyte Cells
We were delighted to speak with Mikael Rydén (Honorary Secretary EASD 2020 and Karolinska Institutet, Stockholm, Sweden) about the ongoing research in his group around human white adipocyte cells. Speaker Disclosures: Mikael Rydén has nothing to disclose in relation to this video. Support: Interview and filming supported by Touch Medical Media. Filmed as a highlight […]
Teresa Quattrin, EASD 2020 – What Does the Future Hold for Paediatric Type 1 Diabetes Patients?
We were delighted to speak with Teresa Quattrin (University at Buffalo, Oishei Children’s Hospital) at virtual EASD 2020 to talk about the treatment landscape for children with type 1 diabetes and what the future holds. Speaker Disclosures: Tersea Quattrin discloses the following: Consultant to Janssen Research & Development Clinical Trial, Principal Investigator at the Buffalo […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!